2026 ICD-10-CM Diagnosis Code C57.8Malignant neoplasm of overlapping sites of female genital organs
ICD-10-CM Codes›C00–D49›C51-C58›C57
- Billable — Valid for Submission
- Chronic Condition
C57.8 is a billable ICD-10-CM diagnosis code for malignant neoplasm of overlapping sites of female genital organs. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 736 through 741, 754 through 756. Coders also document this condition as overlapping malignant neoplasm of female genital organs. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Female reproductive system cancers - all other types.
Code Identity
Code Classification
Approximate SynonymsGuidance
Alternate terms and clinical phrases that map to this code.
- Overlapping malignant neoplasm of female genital organs
Tabular List NotesGuidance
Coding notes and annotation back-references applicable to this code.
Inclusion Terms
- Primary malignant neoplasm of two or more contiguous sites of the female genital organs whose point of origin cannot be determined
- Primary tubo-ovarian malignant neoplasm whose point of origin cannot be determined
- Primary utero-ovarian malignant neoplasm whose point of origin cannot be determined
These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of "other specified" codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.
Clinical ClassificationClinical
AHRQ’s CCSR groups this code into broader clinical categories.
Table of NeoplasmsClinical
Patient EducationClinical
Cervical Cancer
Cervical cancer is cancer that starts in the cells of the cervix. The cervix is part of the female reproductive system. It is the lower, narrow end of the uterus (womb), which opens into the vagina (birth canal).
The full article covers:
- What is cervical cancer?
- What causes cervical cancer?
- Who is more likely to develop cervical cancer?
- What are the symptoms of cervical cancer?
- How is cervical cancer diagnosed?
- What are the treatments for cervical cancer?
- Can cervical cancer be prevented?
Read the full article at MedlinePlus
Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.
Convert C57.8 to ICD-9-CMHistory
The closest ICD-9-CM equivalents under the General Equivalence Mappings.
Code HistoryHistory
Questions About C57.8Overview
Is C57.8 a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report malignant neoplasm of overlapping sites of female genital organs on HIPAA-covered claims from October 1, 2025 through September 30, 2026.
What MS-DRG does C57.8 group to?
When malignant neoplasm of overlapping sites of female genital organs is the principal diagnosis on an inpatient stay, it groups to MS-DRG 736, 737, 738, 739, 740, 741, 754, 755, 756, with relative weights from 0.9605 to 3.5745 depending on complications. Higher weights mean higher Medicare reimbursement.
What is the ICD-9 equivalent of C57.8?
Under the General Equivalence Mappings, malignant neoplasm of overlapping sites of female genital organs converts to ICD-9-CM 184.8 (mal neo female genit NEC). The mapping is approximate, so confirm the match fits the documentation.
Footnotes
[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:
- The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
- The condition places limitations on self-care, independent living, and social interactions.
